The Meis3 protein and retinoid signaling interact to pattern the Xenopus hindbrain  by Dibner, Charna et al.
www.elsevier.com/locate/ydbio
Developmental Biology 271 (2004) 75–86The Meis3 protein and retinoid signaling interact to pattern
the Xenopus hindbrain
Charna Dibner,a Sarah Elias,a Rachel Ofir,a Jacob Souopgui,b Peggy J. Kolm,c Hazel Sive,c
Tomas Pieler,b and Dale Franka,*
aDepartment of Biochemistry, Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences,
Technion-Israel Institute of Technology, Haifa 31096, Israel
bGeorg-August-Universitat Gottingen, Institut fur Biochemie and Molekulare Zellbiologie, D-37030, Gottingen, Germany
cWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA
Received for publication 16 September 2003, revised 11 February 2004, accepted 25 February 2004
Available online 27 April 2004Abstract
In Xenopus embryos, proper hindbrain formation requires activities of both XMeis3 protein and retinoic acid (RA) signaling. In this study,
we show that XMeis3 protein and RA signaling differentially interact to regulate hindbrain patterning. The knockdown of XMeis3 protein
prevented RA-caudalizing activity from inducing hindbrain marker expression in both explants and embryos. In contrast, inhibition of RA
signaling differentially modulated XMeis3 activity. Target genes that are jointly activated by either RA or XMeis3 activities could not be
efficiently induced by XMeis3 when RA signaling was inhibited. However, transcription of an XMeis3 target gene that is not an RA target
gene was hyper-induced in the absence of retinoid signaling. Target genes jointly induced by RA or XMeis3 protein were synergistically
activated in the presence of both activities, while RA treatment inhibits the ability of XMeis3 to activate transcription of neural genes that are
not RA targets. HoxD1, an RA direct-target gene was also identified as an XMeis3 direct-target gene. HoxD1 protein acts downstream of
XMeis3 to induce hindbrain marker gene transcription. To pattern the hindbrain, RA requires functional XMeis3 protein activity. XMeis3
protein appears crucial for initial hindbrain induction, whereas RA signaling defines the spatial limits of hindbrain gene expression by
modifying XMeis3 protein activity.
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Introduction factors caudalize neural tissue in Xenopus embryos andIn the developing Xenopus central nervous system (CNS),
brain pattern is established by a multistep inductive process
(Nieuwkoop, 1952). In the first step, anterior forebrain tissue
is induced throughout the whole brain by BMP antagonist
molecules secreted from Spemann’s organizer (reviewed in
Doniach, 1993; Harland and Gerhart, 1997). In a second
inductive wave, anteriorized neural tissue is caudalized to
more posterior brain cell fates, such as the mid-hindbrain
boarder and hindbrain (Doniach, 1993). Three secreted0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: dale@tx.technion.ac.il (D. Frank).explants: retinoic acid (RA), fibroblast growth factor
(FGF), and Xwnt3a (Cox and Hemmati-Brivanlou, 1995;
Domingos et al., 2001; Durston et al., 1989; Godsave et al.,
1998; Holowacz and Sokol, 1999; Kenkgaku and Okamoto,
1995; Kolm and Sive, 1995; Lamb and Harland, 1995;
McGrew et al., 1995, 1997; Papalopulu and Kintner, 1996;
Ribisi et al., 2000; Ruiz i Altaba and Jessell, 1991; Sharpe,
1991; Sive et al., 1990). These three caudalizing pathways
interact to regulate A–P pattern formation in the nervous
system; however, these molecules are not equivalent in their
caudalizing activities (Kolm et al., 1997; review in Gamse
and Sive, 2000).
RA and its metabolites, the retinoids, are required for
cell differentiation in many systems. Deficiencies in reti-
noid metabolism are associated with severe defects during
vertebrate embryonic development; similarly, administra-
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alters pattern formation in the limb buds and in the
developing nervous system. Vertebrate neural development
is particularly sensitive to RA signaling. Ectopic applica-
tion of RA during Xenopus gastrulation results in the
formation of embryos with severe anterior truncations
(Durston et al., 1989; Ruiz i Altaba and Jessell, 1991;
Sharpe, 1991; Sive et al., 1990). Ectopic RA treatment
differentially alters cell fate along the A–P axis in two
ways; at low concentrations, hindbrain development is
perturbed, and at higher concentrations, anterior neural
tissues like forebrain and cement gland are lost (Godsave
et al., 1998). Ectopic RA causes a loss of anterior hind-
brain, with a subsequent expansion of posterior hindbrain
tissue (Chen et al., 2001; Godsave et al., 1998). In Xenopus
embryos expressing RA signaling antagonist or RA syn-
thesis inhibitor molecules, posterior hindbrain tissue is
perturbed (Blumberg et al., 1997; Hollemann et al., 1998;
Kolm et al., 1997; Van der Wees et al., 1998). Forebrain
and anterior hindbrain tissues are often expanded as a result
of RA activity antagonism (Blumberg et al., 1997; Holle-
mann et al., 1998; Koide et al., 2001; Kolm et al., 1997).
It is still not clear how RA mechanistically acts to pattern
the developing CNS. Little is known about proteins, which
interact with the RA pathway to mediate its caudalizing
effects. RA activates expression of many Hox genes, which
play a role in CNS A–P patterning decisions (reviewed in
Lufkin, 1997). In Xenopus, two early expressed labial Hox
genes, HoxA1 and HoxD1, were shown to be RA direct-
target genes, but their role in CNS A–P pattern formation is
still unclear (Kolm and Sive, 1995). One major question
regarding posteriorization by the RA pathways is, ‘‘What
are the roles of transcription factors, which may respond to
or mediate the effects of caudalizers like RA?’’
One candidate protein that regulates hindbrain formation
and could interact with RA signaling in the CNS is the
Xenopus Meis3 (XMeis3) homeobox transcription factor
(Dibner et al., 2001; Salzberg et al., 1999). XMeis3 expres-
sion is initially detected as a stripe in the presumptive
neuroectoderm as early as mid-gastrula stages, where it
becomes localized in rhombomeres two, three, and four,
and the anterior spinal cord (Salzberg et al., 1999). Genetic
and knockdown studies in Xenopus and zebrafish embryos
have demonstrated a strong requirement for the Meis3
protein in proper hindbrain formation (Dibner et al., 2001;
Vlachakis et al., 2001; Waskiewicz et al., 2001). Knock-
down of the XMeis3 protein in Xenopus embryos causes a
posterior expansion of the forebrain with a concomitant loss
of hindbrain cell fates; pan-neural marker expression was
unaltered in these embryos (Dibner et al., 2001). Comple-
menting these results, ectopic XMeis3 expression in animal
cap explants or embryos activates expression of posterior
neural markers without inducing pan-neural marker expres-
sion (Salzberg et al., 1999). Thus, XMeis3 like RA appears
to be exclusively involved in neural patterning, since it does
not induce neural tissue.In this study, we show that XMeis3 protein and RA
signaling differentially interact to regulate hindbrain pattern.
Knockdown of XMeis3 activity prevents the ability of RA to
pattern the hindbrain in embryos and explants, whereas
antagonism of RA activity prevents XMeis3 transcriptional
activation of RA target genes in explants and embryos. RA
target gene transcription is synergistically activated in the
presence of RA/XMeis3 activities, while RA treatment inhib-
its the ability of XMeis3 to activate transcription of a non-RA
target hindbrain gene. In the absence of RA activity, this gene
undergoes super-induction by XMeis3 in embryos. These
results suggest that the extent of RA signaling in a given cell
can differentially modify XMeis3 caudalizing activity. When
RA signaling is high, a biased expression favoring RA target
genes is observed, but when RA signaling is low, RA target
genes are suppressed and non-RA target gene expression is
enhanced. HoxD1 is an RA direct-response gene (Kolm and
Sive, 1995), which we now show is also an XMeis3 direct-
response gene. HoxD1 and XMeis3 proteins appear to
interact to activate hindbrain gene expression. Thus, com-
bined RA and XMeis3 activity interactions establish correct
A–P pattern in the developing Xenopus hindbrain.Materials and methods
Xenopus embryos, explants, and inducing factors
Ovulation, in vitro fertilization, embryo culture, and
dissections were carried out as described (Re’em-Kalma et
al., 1995). Embryos were staged according to Nieuwkoop
and Faber (1967). Explants removed at blastula stages or
whole embryos were treated with all-trans retinoic acid
(0.01–1.0 AM) at early gastrula stages 10+/10.25. Embryos
and explants were typically cultured in RA to stages 15–18.
RNA, DNA, and morpholino oligonucleotide injections
Different concentrations of capped sense in vitro tran-
scribed full-length mRNA, XMeis3 (Salzberg et al., 1999),
XMeis3-AM, (Dibner et al., 2001), XCYP26 (Hollemann et
al., 1998), RALDH2 (Chen et al., 2001), Xpbx1 (Maeda et
al., 2002), HoxD1, and HoxD1-Eng (Kolm and Sive,
unpublished) were injected into the animal hemisphere of
one blastomere in embryos at the one- or two-cell stages.
Plasmids containing an rpt3-Luciferase reporter gene con-
struct (in pGL3 basic-Promega) or an rpt3-CAT reporter
gene construct (driven by a minimal adenovirus major late
promoter; Kolm and Sive, unpublished) were injected at a
concentration of 50 pg/embryo. The rpt3 enhancer element
binds labial and pbx proteins to drive gene expression in
the mouse HoxB1 gene (Chan et al., 1996; Popperl et al.,
1995). A mutant nonresponsive version of the reporter
construct was also injected in parallel (Chan et al., 1996).
Extract preparation and luciferase assays were performed
using the Luciferase Assay System (Promega) and activity
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using a Berthold luminometer. Luciferase activity was
normalized to total protein concentration. Antisense mor-
pholino oligonucleotides (MOs) complementing the 5V
region of the XMeis3 mRNA (Dibner et al., 2001) were
purchased from Gene Tools, LLC (Philomath, Oregon,
USA) (www@gene-tools.com). In two-cell stage embryos,
one blastomere was injected with 7.5 ng in a 5-nl volume.
The uninjected side serves as an internal control in all
experiments.
XMeis3-GR inducible protein
A full-length XMeis3 fragment was generated by PFU
DNA polymerase. This fragment was cloned 5V to the amino
terminus of the hormone-binding domain of the human
glucocorticoid receptor (hGR) in the pCS2 vector. RNA
encoding the XMeis3-GR fusion protein was injected at the
one-cell stage. Animal cap explants were removed at late
blastula stages for culture. Dexamethasone (10 AM) was
added at stages 10.25–10.5. Cyclohexamide (5 AM) wasFig. 1. XMeis3 and RA cooperatively regulate HoxD1 expression. Two-cell alb
blastomere. All embryos are injected on the right side, viewed dorsally, and are ori
XMeis3 RNA, HoxD1 expression is increased in 67% of the embryos (n = 30/45). (C
52% of the embryos (n = 11/21). (D) 0.1 AM RA (uninjected), HoxD1 expression i
RNA; 0.1 AMRA, HoxD1 expression is highly increased in 71% of the embryos (n
in 66% of the embryos (n = 21/32). (G) 0.8 ng XCYP26 RNA; 50 pg h-gal RNA, H
XCYP26 RNA; 0.8 ng XMeis3 RNA; 50 pg h-gal RNA, HoxD1 expression is readded 30 min before the dexamethasone treatment. In these
experiments, explants were cultured until stages 12.5–13.0
and total RNA was isolated for RT-PCR analysis.
In situ hybridization
Whole-mount in situ hybridization was carried out with
digoxigenin-labeled probes (Harland, 1991; Hemmati-Bri-
vanlou et al., 1990). Embryos were cultured until early to
late neurula stages and subsequently fixed for in situ
hybridization. The uninjected side serves as an internal
control in all experiments. In some embryos, for lineage
tracing analysis, 50 pg of RNA encoding the h-galactosi-
dase protein (h-gal; Smith and Harland, 1991) and various
injected RNAs were co-injected unilaterally at the two-cell
stage. Embryos were stained for h-gal activity and fixed for
whole-mount in situ hybridization as described (Bonstein et
al., 1998). Perturbations of gene expression were always
observed on the co-injected side. Probes used were HoxD1
(Kolm et al., 1997), HoxB3 (Godsave et al., 1998), and
Krox20 (Bradley et al., 1992).ino embryos were injected unilaterally into the animal hemisphere of one
ented anterior (top), posterior (bottom). (A) Control (uninjected). (B) 0.8 ng
) 7.5 ng of XMeis3MO; 50 pg h-gal RNA, HoxD1 expression is reduced in
s anteriorly expanded in 98% of the embryos (n = 61/62). (E) 0.8 ng XMeis3
= 27/38). (F) 7.5 ng XMeis3MO; 0.1 AM RA, HoxD1 expression is reduced
oxD1 expression is reduced in 70% of the embryos (n = 16/23). (H) 0.8 ng
duced in 90% of the embryos (n = 18/20).
ental Biology 271 (2004) 75–86RT-PCR analysis
RT-PCR was performed as described (Wilson and Mel-
ton, 1994), except that random hexamers (100 ng/reaction)
were used for reverse transcription. Primers used for PCR
were EF1a, Krox20, HoxB9 (Hemmati-Brivanlou and Mel-
ton, 1994), HoxD1, RARa2.2 (Kolm et al., 1997), HoxB1,
B3, and B4 (Hooiveld et al., 1999).
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Functional XMeis3 protein is required for RA caudalizing
activity
To determine the epistatic relationship between XMeis3
protein and neural caudalizing pathways, RA activity was
examined in embryos knocked down by XMeis3-MO ex-
pression. Embryos at the two-cell stage were injected with
XMeis3-MO in one blastomere, treated with RA at early
gastrula stages, and grown to neurula stages for neuralFig. 2. XMeis3 and RA cooperatively regulate HoxB3 expression. Two-cell alb
blastomere. All embryos are injected on the right side, viewed dorsally, and are ori
HoxB9 staining). (B) 0.8 ng XMeis3 RNA (HoxB3 and HoxB9 staining) HoxB3
XMeis3 MO (only HoxB3), HoxB3 expression is reduced in 73% of the embryos (
anteriorly expanded in 94% of the embryos (n = 33/35). (E) 0.8 ng XMeis3 RN
increased in 67% of the embryos (n = 22/33). (F) 7.5 ng XMeis3 MO; 0.1 AM RA
(n = 34/37). (G) 0.8 ng XCYP26 RNA; 50 pg h-gal RNA (only HoxB3), HoxB3
XCYP26 RNA; 0.8 ng XMeis3 RNA; 50 pg h-gal RNA (only HoxB3), HoxB3 emarker expression analysis. In RA-treated embryos, HoxD1
and HoxB3 expression patterns were anteriorized versus
controls (compare Figs. 1A and 2A to Figs. 1D and 2D).
RA also induced an anteriorly fused single r5-like stripe of
Krox20 expression (compare Figs. 3A to D). However, RA
treatment could not rescue the effects of hindbrain elimina-
tion by the XMeis3-MO, as seen by the loss of HoxD1
(compare Figs. 1C to F), HoxB3 (compare Figs. 2C to F)
and Krox20 (compare Figs. 3C to F) expression. In fact, the
joint effect of RA and the XMeis3-MO seemed to enhance
the hindbrain-loss phenotype. Thus, the anterior expansion
and expression of posterior hindbrain markers in RA-treated
embryos cannot occur in the absence of XMeis3 protein
activity.
A complementary observation was detected for hindbrain
marker expression in animal cap explants expressing the
XMeis3 antimorph protein (XMeis3-AM). XMeis3-AM
encoding RNA was injected into one-cell embryos and
animal caps were removed at blastula stages for RA treat-
ment. In XMeis3-AM/RA-treated animal cap explants, there
was a large decrease in expression of RA-activated hind-ino embryos were injected unilaterally into the animal hemisphere of one
ented anterior (top), posterior (bottom). (A) Control (uninjected; HoxB3 and
expression is increased in 44% of the embryos (n = 18/41). (C) 7.5 ng of
n = 25/34). (D) 0.1 AM RA (uninjected; only HoxB3) HoxB3 expression is
A; 0.1 AM RA (HoxB3 and HoxB9 staining), HoxB3 expression is highly
(only HoxB3), HoxB3 expression is highly reduced in 92% of the embryos
expression is posteriorized in 68% of the embryos (n = 13/19). (H) 0.8 ng
xpression is reduced in 82% of the embryos (n = 23/28).
Fig. 3. RA modulates XMeis3 activation of Krox20 expression. Two-cell albino embryos were injected unilaterally into the animal hemisphere of one
blastomere. All embryos are injected on the right side, viewed dorsally, and are oriented anterior (top), posterior (bottom). (A) Control (uninjected). (B) 0.8 ng
XMeis3 RNA, Krox20 expression is increased in 70% of the embryos (n = 62/89). (C) 7.5 ng of XMeis3 MO, Krox20 expression is decreased in 68% of the
embryos (n = 32/47). (D) 0.1 AM RA (uninjected), Krox20 expression stripes are fused in 98% of the embryos (81/83). (E) 0.8 ng XMeis3 RNA; 0.1 AM RA,
ectopic Krox20 expression is decreased in 78% of the embryos (n = 62/80). (F) 7.5 ng XMeis3 MO; 0.1 AM RA; 50 pg h-gal RNA, Krox20 expression is
decreased in 89% of the embryos (n = 49/55). (G) 0.8 ng XCYP26 RNA, Krox20 expression is posteriorized in 89% of the embryos (17/19). (H) 0.8 ng XCYP26
RNA; 0.8 ng XMeis3 RNA, Krox20 expression is highly expressed in 68% of the embryos (13/19).
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and HoxB4, in comparison to explants solely treated with
RA (Fig. 4A). Thus, inhibition of XMeis3 activity by the
XMeis3-AM protein significantly inhibited RA caudalizing
activity in animal cap explants.
Retinoid signaling simultaneously synergizes and
antagonizes XMeis3 caudalizing activity
To further determine how XMeis3 protein interacts with
RA signaling pathways, we treated embryos expressing the
XMeis3 protein with RA. Embryos at the two-cell stage
were injected with XMeis3 encoding RNA in one blasto-
mere. At early gastrula stage, embryos were treated with
RA. Whole-mount in situ hybridization of treated embryos
showed that the combination of XMeis3 and RA maximally
activated expression of the RA target genes HoxD1 and
HoxB3 versus embryos only expressing XMeis3 or treated
with RA (compare Figs. 1E and 2E to (Figs. 1A and 2A, 1B
and 2B, and 1D and 2D)).
Similar to the HoxB3 and HoxD1 genes, XMeis3
ectopically spread Krox20 expression on the injected side(compare Figs. 3B to A); however, in sharp contrast to the
HoxB3 and HoxD1 genes, RA treatment did not enhance
but alleviated this effect (compare Figs. 3B to E). RA
treatment reduced the XMeis3-induced Krox20 posterior
spread to a fused stripe in the expanded r5 region, similar
to the non-injected RA-treated side of the embryo, which
resembles the non-XMeis3-injected RA-treated embryos
(compare Figs. 3E to D). Unlike the HoxB3 and HoxD1
genes, Krox20 is not an RA target gene; XMeis3, but not
RA, activates its expression in animal cap explants. Thus,
in addition to caudalizing the hindbrain, RA also limits the
regional spread of XMeis3-induced Krox20 expansion
along the A–P axis, suggesting that RA and XMeis3
may differentially interact to establish pattern in the CNS.
Common XMeis3/RA target genes are expressed synergis-
tically in the presence of both activators. However, in the
case of a non-RA XMeis3 target gene, like Krox20,
increasing RA levels inhibits its transcriptional activation
by XMeis3 protein.
To extend these studies, we also examined the ability of
XMeis3 to activate posterior neural marker gene expression
in animal cap explants treated with RA. XMeis3-injected
Fig. 4. XMeis3 and RA interactions in animal cap explants. (A) One-cell stage embryos were injected in the animal hemisphere with 1.6 ng of XMeis3-
antimorph (AM) encoding RNA. Eighteen animal cap explants were removed from uninjected and injected groups of blastula embryos (stage 8–9) and treated
with RA (1.0 AM) at stage 10.25. Explants from each group were grown to stage 18 and total RNA was isolated. RT-PCR analysis was performed with the
markers HoxD1, RARa2.2, HoxB1, HoxB3, and HoxB4. EF1a served as a control for quantitating RNA levels in the different samples. For controls, RT-PCR
and -RT-PCR was performed on total RNA isolated from normal embryos. (B) One-cell stage embryos were injected in the animal hemisphere with 1.6 ng of
XMeis3 encoding RNA. Eighteen animal cap explants were removed from uninjected and injected groups of blastula embryos (stage 8–9) and treated with RA
(0.1 AM). Explants from each group were grown to stage 18 and total RNAwas isolated. RT-PCR analysis was performed with the markers: HoxB9, Krox20,
RARa2.2, and HoxD1. EF1a served as a control for quantitating RNA levels in the different samples. For controls, RT-PCR and -RT-PCR was performed on
total RNA isolated from normal embryos. (C) One-cell stage embryos were injected in the animal hemisphere with either 1.6 ng of XMeis3 or XCYP26
encoding RNAs. Eighteen animal cap explants were removed from uninjected and injected groups of blastula embryos (stage 8–9). Explants from each group
were grown to stage 18 and total RNAwas isolated. RT-PCR analysis was performed with the markers: Krox20, HoxB3, and HoxD1. EF1a served as a control
for quantitating RNA levels in the different samples. For controls, RT-PCR and -RT-PCR was performed on total RNA isolated from normal embryos.
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HoxD1, and RARa2.2 mRNAs in comparison to uninjected
control animal cap explants (Fig. 4B). RA treatment of
animal cap explants activated expression of the RA target
genes, HoxD1 and RARa2.2; however, RA treatment of
animal cap explants strongly inhibited the XMeis3-induced
transcription of non-RA target genes, like Krox20 andHoxB9 (Fig. 4B). In contrast, the combination of RA
treatment and ectopic XMeis3 expression synergistically
activated transcription of the HoxD1 and RARa2.2 RA-
responsive genes (Fig. 4B). These results were observed
over a 100-fold concentration range of RA (0.01–1.0 AM;
not shown). In parallel, experiments were also performed in
animal caps ectopically expressing the RA activating en-
Fig. 5. RA signaling modifies XMeis3 expression along the A–P axis. Two-
cell albino embryos were injected unilaterally into the animal hemisphere
with XCYP26 or RALDH2 encoding RNAs. The injected side is on the left
as marked by h-gal staining (blue) and all embryos are viewed dorsally with
anterior on top and posterior at the bottom. (A) 0.5 ng of XCYP26 RNA,
XMeis3 expression is shifted posteriorly in the hindbrain, and inhibited in
the spinal cord in 100% of the embryos (86/86). The gap between hindbrain
and spinal cord expression was narrowed or lost in 82% of the embryos
(70/86). (B) 2.0 ng of RALDH2 RNA, XMeis3 expression is slightly shifted
anteriorly, laterally expanded in the anterior spinal cord (as indicated with
the dashed line) in 68% of the embryos (37/54). Expression in the
hindbrain was not increased. (C) 2.0 ng of RALDH2 RNA and treatment
with 500 nm all-trans-retinal (ATR) at stage 10.5. Similar phenotypes
described in B were observed, including no increase in hindbrain expression,
a slight anterior shift, and a lateral expansion of XMeis3 expression in 74%
(35/48) of the embryos. (D) 18 nM RA treatment at gastrula stage 10.5.
XMeis3 expression was strongly shifted anteriorly and increased in the
spinal cord in 100% (76/76) of the embryos.
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retinoid substrate, all-trans-retinal (ATR). When explants
were activated in the presence of ATR (1.5 AM) and
RALDH2, XMeis3-induced gene expression patterns were
modified. Similar to RA explant treatment, XMeis3 induc-
tion of Krox20 expression was inhibited in the presence of
ATR and RALDH2 (not shown). Expression of RA induc-
ible genes, such as RARa2.2 and HoxB3, was synergisti-
cally stimulated by the combination of XMeis3, ATR, and
RALDH2 (not shown). Thus, like in whole embryos,
XMeis3 and RA signaling interact to simultaneously mod-
ulate A–P-specific hindbrain marker gene expression in
explants.
XMeis3/RA response genes require RA signaling for
activation by XMeis3
To further investigate a functional interaction between
XMeis3 protein and retinoid signaling, XMeis3 protein was
co-expressed with the RA hydroxylase, XCYP26 (Holle-
mann et al., 1998). XCYP26 antagonizes RA signaling by
inhibiting endogenous retinoid biosynthesis. Embryos were
co-injected in one blastomere at the two-cell stage with
XMeis3 and XCYP26 encoding RNAs. The co-expression
of XMeis3 and XCYP26 led to a dramatic posterior and
lateral expansion of Krox20 expression levels (Fig. 3H), in
comparison to embryos expressing either XMeis3 or
XCYP26 RNAs alone (Figs. 3B, G). This observation again
supports the idea that expression of XMeis3/non-RA target
genes may be negatively regulated by RA signaling. We
also examined expression of the two RA target genes
(HoxB3 and HoxD1), which are also induced by ectopic
XMeis3. In XMeis3-expressing embryos, HoxD1 expres-
sion is expanded on the injected side (Figs. 1B); a slight
but reproducible expansion of HoxB3 is also observed (Fig.
2B). In XCYP26-expressing embryos, there is a reduction
and posterior shift in HoxD1 and HoxB3 expression (Figs.
1G and 2G). In XMeis3/XCYP26 co-expressing embryos,
there is an even stronger inhibition of HoxD1 and HoxB3
expression levels in comparison to the effects of XCYP26
alone (Figs. 1H and 2H). Thus, while inhibition of RA
signaling by XCYP26 protein stimulated the ability of
XMeis3 to activate Krox20 expression, XMeis3/RA target
genes were poorly expressed in the same embryos. Experi-
ments in animal cap explants also supported these obser-
vations. The XMeis3 and XCYP26 proteins were co-
expressed in animal cap explants (Fig. 4C). As in embryos,
XMeis3 activity was modified in a differential manner.
Ectopic XCYP26 expression inhibited XMeis3 activation of
RA-responsive genes, such as HoxD1 and HoxB3 by at least
fourfold; in contrast, XMeis3 activation of Krox20 expres-
sion was stimulated twofold by RA antagonism (Fig. 4C).
These results suggest that XMeis3 protein activity is
differentially regulated by RA signaling. High or low
levels of RA signaling can modulate XMeis3 protein
activity in the embryo. In cells with low RA activity, aKrox20-like pathway of gene expression is favored and
RA target gene expression is repressed; however, at high
RA levels, XMeis3/RA target gene expression is maximal
and expression of non-RA target genes like Krox20 is
inhibited.
RA signaling modifies XMeis3 expression along the A–P
axis
To determine if RA signaling can regulate XMeis3
expression, two-cell stage embryos were injected in one
blastomere with either XCYP26- or RALDH2-encoding
RNAs. Ectopic XCYP26 activity did not eliminate XMeis3
mRNA levels in the hindbrain, but caused a posterior shift
in its expression (Fig. 5A). Previous studies in embryos
expressing ectopic XCYP26 levels have shown an identical
posterior shift in hindbrain gene expression for markers
such as Krox20, Pax6, and HoxB3 (Hollemann et al., 1998).
The typical gap in XMeis3 expression between the posterior
C. Dibner et al. / Developmental Biology 271 (2004) 75–8682hindbrain and the anterior spinal cord was lost in XCYP26-
expressing embryos (Fig. 5A). This expression pattern is
nearly identical to the expression pattern of XMeis3 in mild
XMeis3-MO knockdown phenotypes (Dibner et al., 2001).
Also, in mild XMeis3 knockdown phenotypes, hindbrain
Krox20 expression shifted posteriorly (Dibner et al., 2001).
These observations and the differential effects of XMeis3/
XCYP26 co-injection on neural marker expression highlyFig. 6. HoxD1 is an XMeis3 direct-target gene that interacts with XMeis3 to activat
the animal hemisphere with 1.6 ng of inducible XMeis3-GR encoding RNAs. Fifty
uninjected and injected groups of blastula embryos (stage 8–9). Eighteen explants
Materials and methods) to stage 12.5 and total RNA was isolated. RT-PCR analys
control for quantitating RNA levels in the different samples. For controls, RT-PCR
(B) One-cell stage embryos were injected in the animal hemisphere with either 1.6
removed from uninjected and injected groups of blastula embryos (stages 8–9). Ex
RT-PCR analysis was performed with the markers: Krox20 and HoxB3. EF1a se
controls, RT-PCR and -RT-PCR was performed on total RNA isolated from norm
animal hemisphere of one blastomere with RNAs encoding XMeis3 or HoxD1
embryos. All embryos are injected on the left side, viewed dorsally, and are oriente
right panel: XMeis3 injected (0.8 ng), 70% of the embryos had expanded Krox2
expanded Krox20 expression (0/27). XMeis3 and HoxD1 co-injected (0.8 ng), 68%
co-injected with the rpt3-luc or rpt3-CAT reporter constructs (see Materials and me
representative experiment is shown. At early-mid gastrula stages, 10 embryos were
describes relative luciferase activity in each sample, with the control embryos expr
reporter did not activate luc transcription (not shown) in injected embryos.suggest that antagonism of RA signaling does not likely
mediate its effects on XMeis3 activity by simply turning off
gene transcription.
RALDH2-injected embryos were treated with ATR at
early gastrula stages. RALDH2, RALDH2/ATR, or RA
treatments led to an anterior expansion of XMeis3 expression
(Figs. 5B–D). A similar anterior expansion was also shown
for Krox20 expression in the hindbrain of RALDH2/ATR-e hindbrain marker expression. (A) One-cell stage embryos were injected in
-four and seventy-two animal cap explants were respectively removed from
from each group were grown in cyclohexamide and/or dexamethasone (see
is was performed with the markers: Krox20 and HoxD1. EF1a served as a
and -RT-PCR was performed on total RNA isolated from normal embryos.
ng of XMeis3 or HoxD1 encoding RNAs. Eighteen animal cap explants were
plants from each group were grown to stage 18 and total RNAwas isolated.
rved as a control for quantitating RNA levels in the different samples. For
al embryos. (C) Two-cell albino embryos were injected unilaterally into the
proteins. In situ hybridization to Krox20 was performed in neurula stage
d anterior (top), posterior (bottom). Upper left panel: control embryo. Upper
0 expression (62/89). HoxD1 injected (0.8 ng), none of the embryos had
of the embryos had ectopic Krox20 expression (28/41). (D) Embryos were
thods) along with RNAs encoding HoxD1, Xpbx1, or XMeis3 proteins. One
lysed per injection group and luciferase activity was assayed. The bar graph
essing only the rpt3-luc reporter taken as 1. A mutant version of the rpt3-luc
C. Dibner et al. / Developmental Biology 271 (2004) 75–86 83treated embryos (Chen et al., 2001). XMeis3 expression
levels expanded laterally in the spinal cord, but in the
hindbrain, no increased XMeis3 mRNA levels were
detected (Figs. 5B–D). Our previous studies have shown
that RA cannot efficiently induce XMeis3 expression in
animal cap explants. Together, these results suggest that
RA is not a major mediator of XMeis3 transcriptional
activation per se, but that XMeis3 protein and the RA
signaling cascade intermesh to regulate A–P pattern in the
hindbrain.
HoxD1 is an XMeis3 direct-target gene
To reveal the pathways downstream of XMeis3 protein,
experiments were performed to identify XMeis3 direct-
target genes. An XMeis3 growth hormone receptor fusionFig. 7. HoxD1 protein acts downstream of XMeis3. Two-cell albino embryos we
RNAs encoding XMeis3 and HoxD1-Eng (antimorph) proteins or XMeis3-MO
performed in neurula stage embryos. All embryos are injected on the left side, view
(uninjected). (B) 0.8 ng XMeis3 RNA, Krox20 expression was increased in 81% o
lost in 90% of the embryos (20/22). (D) 0.8 ng XMeis3 RNA, 0.1 ng HoxD1-Eng
inhibited in 93% of the embryos (13/14). (E) 18 ng XMeis3-MO, Krox20 expressi
was fairly normal on both sides in 13.5% of the embryos (7/52). (F) 18 ng XMeis3
was fairly normal in 58% of the embryos (14/24). Krox20 expression was highly
HoxD1 RNA resembled uninjected controls (see Fig. 6C). Similar results were oprotein (XMeis3-GR) was constructed that could be acti-
vated only in the presence of dexamethasone (dex). In
injected animal cap explants, inducible XMeis3-GR pro-
tein activated posterior neural marker expression in the
presence of dex (Fig. 6A, data not shown). Uninjected
dex-treated animal caps or animal caps expressing the
XMeis3-GR in the absence of dex did not express poste-
rior neural markers (Fig. 6A). To identify XMeis3 direct-
response genes, blastula stage animal caps expressing the
XMeis3-GR were pretreated with cyclohexamide (chx; see
Materials and methods) before the addition of dex.
Explants were grown to late gastrula/early neurula stages
in the presence of dex/chx, and RNA was isolated for RT-
PCR analysis. We examined a wide array of posterior
markers normally induced by XMeis3 protein in animal
cap explants such as various Hox genes (not shown) asre injected unilaterally into the animal hemisphere of one blastomere with
and RNA encoding HoxD1 protein. In situ hybridization to Krox20 was
ed dorsally, and are oriented anterior (top), posterior (bottom). (A) Control
f the embryos (9/11). (C) 0.1 ng HoxD1-Eng RNA, Krox20 expression was
RNA RNA (two representative embryos), ectopic Krox20 expression was
on was highly inhibited in 75% of the embryos (39/52), Krox20 expression
MO, 0.8 ng HoxD1 RNA (two representative embryos), Krox20 expression
inhibited in only 21% of the embryos (5/24). Embryos solely expressing
bserved for HoxB3 expression (not shown).
C. Dibner et al. / Developmental Biology 271 (2004) 75–8684well as Krox20. Only one mRNA was detected, whose
level was not inhibited by chx, and this was the HoxD1
gene (Fig. 6A). Interestingly, HoxD1 is also an RA direct-
response gene (Kolm and Sive, 1995). This raises an
interesting point of potential pathway interaction, because
both RA and XMeis3 activities were required for the
correct induction of HoxD1 expression in embryos and
explants (Figs. 1C, G).
To elucidate XMeis3 and HoxD1 interactions, experi-
ments were performed in which XMeis3 and HoxD1 encod-
ing RNAs were co-injected into one-cell embryos and animal
caps were removed at blastula stages for culture until neurula
stages. In animal cap explants, HoxD1 alone could not induce
Krox20 or HoxB3 expression (Fig. 6B), but it significantly
enhanced the ability of XMeis3 to activate their transcription
(Fig. 6B). As in explants, ectopic HoxD1 levels did not
activate Krox20 expression in embryos (Fig. 6C), yet in
HoxD1/XMeis3 co-injected embryos, Krox20 expression
was ectopically induced, in comparison to embryos injected
with XMeis3 alone, especially when XMeis3 induction of
ectopic Krox20 expression was intermediate (Fig. 6C). To
further investigate XMeis3 and HoxD1 interactions, mRNAs
encoding these proteins were co-expressed with a reporter
construct driven by the mouse HoxB1-rpt3 enhancer element
(see Materials and methods). In other studies, the rpt3
element was shown to bind labial/pbx proteins (Chan et al.,
1996; Popperl et al., 1995). We show that the HoxD1 protein
alone moderately stimulated the reporter construct, and pbx
had negative effects (Fig. 6D). When co-injected, pbx and
HoxD1 proteins highly activated the mouse HoxB1 rpt3
enhancer element (Fig. 6D). XMeis3 protein did not signif-
icantly activate trandscription of this reporter, alone or in
combination with pbx or HoxD1 proteins (not shown).
Embryos were co-injected with RNAs encoding XMeis3
and HoxD1-antimorph (Engrailed domain) proteins (Kolm
and Sive, unpublished). The injection of the HoxD1-anti-
morph protein eliminated Krox20 expression in the hindbrain
(Fig. 7C). Overexpression of XMeis3 typically expanded
Krox20 expression (compare Figs. 7A to B), but in co-
injected embryos, XMeis3 activity failed to stimulate Krox20
expression and most of the embryos failed to express signif-
icant Krox20 levels in r3/r5 on the injected side (Fig. 7D).
HoxB3 expression was inhibited in a similar manner (not
shown). In the same HoxD1-antimorph-expressing embryos,
XMeis3 expression was not severely reduced, but in some
cases, shifted posteriorly by one or two rhombomeres (not
shown). Ruling out nonspecific toxic effects, co-injection of
pbx andHoxD1 encoding RNAs rescued hindbrain formation
in embryos expressing the HoxD1-antimorph protein (Kolm
and Sive, unpublished). While ectopic XMeis3 protein ex-
pression cannot rescue the HoxD1-antimorph phenotype,
ectopic HoxD1 expression can efficiently rescue Krox20
(Figs. 7E, F) and HoxB3 (not shown) expression in embryos
knocked down by the XMeis3-MO. These results strongly
suggest that HoxD1 acts downstream of XMeis3 protein in
hindbrain formation.Discussion
In this study, we examined the interaction of the neural
caudalizing activities of XMeis3 protein and RA. Little is
known as to how transcription factors interact with signaling
pathways to pattern the early CNS. Previous studies have
shown that either XMeis3 or RA can pattern ectoderm in the
absence of neural induction and both XMeis3 protein and RA
activities are required for proper hindbrain formation.
XMeis3 is expressed in a single stripe of presumptive
hindbrain cells in mid-gastrula stage embryos and its knock-
down leads to a loss of the whole hindbrain with a concom-
itant expansion of the forebrain. Embryos depleted of RA
activity typically lose the posterior hindbrain and gain some
anterior neural structures. It was suggested that RA might act
in two ways to pattern the Xenopus CNS. RA can induce a
posterior hindbrain, while also inhibiting anterior CNS struc-
tures such as forebrain. Because of these similarities in
XMeis3 and RA activities, we determined the potential
epistatic relationship between XMeis3 protein and RA sig-
naling activities.
XMeis3 protein acts upstream of RA signaling in regu-
lating hindbrain formation. In XMeis3 knockdown embryos
or explants, RA caudalizing activity was diminished; RA
could not rescue hindbrain cell fates nor induce hindbrain
marker expression in XMeis3 knockdown embryos. In
animal cap explants, XMeis3 knockdown significantly
inhibited the ability of RA to activate the expression of a
panel of Hox genes. These results suggest that XMeis3 is
required to initially induce the hindbrain and that RA
endows a distinct A–P character to it.
Further experiments demonstrated that RA greatly mod-
ulates the activity of XMeis3 protein to turn on expression
of posterior neural markers. Ectopic XMeis3 activity indu-
ces expression of a wide range of posterior neural markers in
embryos and animal cap explants. Ectopic XMeis3 expres-
sion in the presence of high RA levels inhibits non-RA
target gene expression in explants and embryos (HoxB9,
Krox20). However, in the same explants and embryos, RA
target genes, such as RARa2.2, HoxB3, and HoxD1, are
expressed at maximal levels by the combination of XMeis3
and RA. In support of this observation, in the absence of RA
signaling, RA target genes are weakly expressed in embryos
and explants, even in the presence of ectopic XMeis3
activity. However, Krox20 gene expression is maximally
induced by XMeis3 in the absence of RA signaling.
These results suggest that the presence or absence of RA
signaling can bias the direction of XMeis3 protein activity in
the embryo. In cells with low RA activity, a Krox20-like
pathway of gene expression is observed with RA target gene
expression being repressed; however, at high RA levels,
XMeis3/RA target gene expression is optimal and expression
of genes like Krox20 is inhibited. In the hindbrain, a correct
spatial and temporal balance of RA signaling is most likely
required to enable proper A–P pattern formation by endog-
enous XMeis3 protein. The RA/XMeis3 interactions that
C. Dibner et al. / Developmental Biology 271 (2004) 75–86 85dictate Krox20 expression levels suggest that XMeis3 may
be responsible for the absolute levels of Krox20 transcripts,
whereas RA signaling may dictate the regional localization
in the hindbrain. Inhibition of XMeis3 protein activity by
strong areas of retinoid signaling may localize Krox20
expression to specific hindbrain regions (r3 and r5). Ectopic
XCYP26 levels disrupt this delicate balance, leading to
expansion of XMeis3-induced Krox20 expression through-
out the CNS. This bimodal regulation of XMeis3 activity
should enable differential gene expression in the hindbrain as
determined by higher or lower areas of RA signaling.
In chick embryos, RA antagonism induced upregulation
of Krox20 expression, presumably by spreading r5 caudally
(Dupe and Lumsden, 2001). These Krox20 positive cells
excluded expression of HoxB1 (Dupe and Lumsden, 2001).
Other studies showed that forced ectopic Krox20 expression
inhibited HoxB1 expression in r4; in these embryos, odd-
numbered rhombomeric identity was superimposed on
even-numbered rhombomeres (Giudicelli et al., 2001). It
was suggested that RA signaling defines the r3/4 boarder
between Krox20 and HoxB1 expressing cells (Dupe and
Lumsden, 2001). XMeis3 is expressed in both even and
odd-numbered rhombomeres (r2–r3–r4) and its activity is
required for formation of the whole hindbrain. Our results
show that XMeis3 can induce Krox20 expression in a
nonautonomous manner (Aamar and Frank, 2004). There-
fore, to build the r3/r4 border and to distinguish odd and
even numbered rhombomeres, RA suppression of XMeis3’s
ability to activate Krox20 expression outside of r3 and r5
could be crucial for defining even numbered rhombomeres.
Presumably, this RA activity would be attenuated in odd-
numbered rhombomeres such as r3 and r5, thus enabling
XMeis3 activation of Krox20 gene expression. In this
manner, RA signaling may modify XMeis3 activity to
properly pattern the hindbrain. In areas of high RA signal-
ing, XMeis3 maximizes activation of RA response gene
expression while minimizing its activation of a non-RA
target gene, such as Krox20.
HoxD1 is an XMeis3 direct-response gene, being tran-
scriptionally activated by XMeis3 in the presence of chx.
Interestingly, HoxD1 was also shown to be an RA direct-
response gene (Kolm and Sive, 1995). HoxD1 and XMeis3
proteins appear to jointly function to activate high levels of
Krox20 and HoxB3 gene transcription in embryos and
explants. Supporting this observation, ectopic expression
of the HoxD1 antimorph protein strongly inhibited XMeis3
caudalizing activity in embryos. Unlike RA inhibition by
XCYP26 protein, which only altered the A–P expression
pattern of hindbrain-expressed genes like Krox20 (Holle-
mann et al., 1998), knockdown of HoxD1 activity, like
knockdown of XMeis3 activity, caused a loss of Krox20
and HoxB3 expression. These results suggest that HoxD1
protein is not working as an antagonistic arm of the RA
signaling pathway to repress XMeis3 activation of Krox20
expression. In contrast, it appears that the activation of
HoxD1 by XMeis3 is a prerequisite for proper hindbrainformation. In HoxD1 knockdown embryos, the ability of
ectopic XMeis3 protein to rescue Krox20 expression is
inhibited, yet ectopic HoxD1 expression can rescue hind-
brain marker expression in XMeis3 knockdown embryos. In
HoxD1 knockdown embryos, the XMeis3 expression pattern
is fairly normal, but in XMeis3 knockdown embryos,HoxD1
expression is strongly inhibited. These results strongly
suggest that HoxD1 protein acts downstream of XMeis3 in
regulating hindbrain formation. XMeis3 activity and RA
signaling are necessary for the optimal expression of HoxD1
mRNA, suggesting that both are required for proper spatial
and temporal regulation of HoxD1 transcription.
While XMeis3 directly regulates HoxD1 transcription,
our results suggest the two proteins could interact to induce
gene expression, since functional HoxD1 protein is required
for proper XMeis3 hindbrain inducing activity and co-
injection of both proteins stimulated transcriptional activa-
tion of Krox20 andHoxB3 in explants and embryos. We have
shown that Xenopus PBX and HoxD1 proteins jointly
activate the mouse HoxB1 promoter element (rpt3), but co-
injection of XMeis3 had negligible effects in activating this
reporter construct. Whether XMeis3 physically interacts with
PBX or HoxD1 proteins to bind DNA and activate transcrip-
tion of certain target genes is still an open question. XMeis3/
HoxD1 ectopic activation of HoxB3 and Krox20 expression
in embryos and explants could occur if XMeis3 was inducing
a prepattern in non-neural regions that allows the HoxD1
protein to activate posterior neural gene expression in these
regions. The rpt3-HoxB1 enhancer element is r4-specific and
may not be the optimal target for activation by co-expression
of XMeis3 with HoxD1/PBX proteins. Additional investiga-
tion of XMeis3/HoxD1/PBX interactions on r3- or r5-spe-
cific promoters should clarify this question. In future experi-
ments, we hope to determine how XMeis3 and HoxD1
proteins act to form the Xenopus hindbrain. Unraveling the
molecular pathways in which RA signaling bimodally mod-
ulates XMeis3 protein activity should enable a better under-
standing of how transcription factors and signaling pathways
mesh to pattern the early vertebrate CNS.Acknowledgments
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